Global Nuclear Medicine Market 2016-2020; New Report Launched

Bangalore, Karnataka -- (SBWire) -- 07/22/2016 --Nuclear medicine is a specialty branch of medical imaging that involves the use of modalities such as SPECT and PET scans. These technologies help detect and evaluate various disorders in the areas of oncology, cardiology, and neurology. Modalities for nuclear medicine involve the use of a minimal amount of radioisotopes that are either injected, swallowed, or inhaled by an individual. These radioisotopes reach the specific organ targeted by the pharmaceutical compound and emit radiations that can be detected using a scanner or a detector.

Report forecast the global nuclear medicine market to grow at a CAGR of 8.34% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global nuclear medicine market for 2016-2020. To calculate the market size, the report considers the use revenue generated from the sales of various types of imaging equipment and radiopharmaceuticals that are used for diagnosis and therapeutic purposes.

The market is divided into the following segments based on geography:
- Americas
- EMEA
- APAC

Global Nuclear Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Cardinal Health
- Digirad
- GE Healthcare
- Lantheus Medical Imaging
- Philips Healthcare
Other prominent vendors

- ABT Molecular Imaging
- Advanced Accelerator Applications
- AGFA Healthcare
- Algeta
- Astellas Pharma
- Bayer
- Bracco Imaging
- Brain Biosciences
- Capintec
- CMR Naviscan
- Cubresa
- Eczacibasi-Monrol Nuclear Products
- FUJIFILM Holdings
- IBA Molecular Imaging
- ISOLOGIC Innovative Radiopharmaceuticals
- Jubilant DraxImage
- Mallinckrodt
- Mediso Medical Imaging System
- Mirada Medical
- Navidea Biopharmaceuticals
- Nordion
- Piramal Imaging
- Positron Pharmaceutical Company
- RadioMedix
- SHINE Medical Technologies
- Sophie Biosciences
- Toshiba Medical Systems
- Triad Isotopes
- Voxel
Market driver
- Growing demand for radiopharmaceuticals
- For a full, detailed list, view our report

Market challenge
- High cost of nuclear medicine and time constraints owing to its short half-life
- For a full, detailed list, view our report

Market trend
- Partnerships for development of nuclear medicine
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 73 pages "Global Nuclear Medicine Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Market segmentation by product, Market segmentation by application, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendors, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-nuclear-medicine-market-2016-2020

Related Report:

Global Systemic Psoriasis Therapeutics Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-systemic-psoriasis-therapeutics-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.